Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pappolla

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Pain Physician|December 5, 2018
Do Regenerative Medicine Therapies Provide Long-Term Relief in Chronic Low Back Pain: A Systematic Review and MetaanalysisJaya Sanapati, Laxmaiah Manchikanti, Sairam Atluri, et al.
Journal of Neurochemistry|February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitorsKumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Journal of Pineal Research|June 21, 2002
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptorsMiguel A Pappolla, Marcia J Simovich, Tara Bryant-Thomas, et al.
Plos One|March 25, 2014
Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β proteinEliza Barnwell, Vasudevaraju Padmaraju, Robert Baranello, et al.
Pain Physician|June 4, 2025
Pain Management in Mild Traumatic Brain Injury: Central Sensitization as a Multispecialty ChallengeChristopher File, Remi Nader, Alejandro Villasante-Tezanos, et al.
Neurobiology of Disease|October 11, 2001
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's diseaseL M Refolo, M A Pappolla, J LaFrancois, et al.
Biochemistry|December 6, 2001
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptideB Poeggeler, L Miravalle, M G Zagorski, et al.
The American Journal of Medicine|March 3, 2010
Higher incidence of mild cognitive impairment in familial hypercholesterolemiaDaniel Zambón, Melibea Quintana, Pedro Mata, et al.
Multiple Sclerosis and Related Disorders|December 18, 2019
Disease activity impacts disability progression in primary progressive multiple sclerosisM Marrodan, C Bensi, A Pappolla, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Pain Physician|December 5, 2018
Do Regenerative Medicine Therapies Provide Long-Term Relief in Chronic Low Back Pain: A Systematic Review and MetaanalysisJaya Sanapati, Laxmaiah Manchikanti, Sairam Atluri, et al.
Journal of Neurochemistry|February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitorsKumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Journal of Pineal Research|June 21, 2002
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptorsMiguel A Pappolla, Marcia J Simovich, Tara Bryant-Thomas, et al.
Plos One|March 25, 2014
Evidence of a novel mechanism for partial γ-secretase inhibition induced paradoxical increase in secreted amyloid β proteinEliza Barnwell, Vasudevaraju Padmaraju, Robert Baranello, et al.
Pain Physician|June 4, 2025
Pain Management in Mild Traumatic Brain Injury: Central Sensitization as a Multispecialty ChallengeChristopher File, Remi Nader, Alejandro Villasante-Tezanos, et al.
Neurobiology of Disease|October 11, 2001
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's diseaseL M Refolo, M A Pappolla, J LaFrancois, et al.
Biochemistry|December 6, 2001
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptideB Poeggeler, L Miravalle, M G Zagorski, et al.
The American Journal of Medicine|March 3, 2010
Higher incidence of mild cognitive impairment in familial hypercholesterolemiaDaniel Zambón, Melibea Quintana, Pedro Mata, et al.
Multiple Sclerosis and Related Disorders|December 18, 2019
Disease activity impacts disability progression in primary progressive multiple sclerosisM Marrodan, C Bensi, A Pappolla, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
Pageof 10